These apparent discrepancies between the studies indicate that the extent to which AR-mediated regulation of eIF4F complex assembly [30] and PERK/eIF2α phosphorylation/ISR [127] contributes to translational perturbations in prostate cancer remains to be established. The gene discussed is AR; the disease is prostate cancer.